Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

A new method effectively predicts estrogen-related health effects for early screening.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Finasteride treatment makes the prostate look more like a healthy one.

Blocking Prostaglandin D₂ may help treat hair loss.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Finasteride may cause changes in dopamine-related genes, possibly leading to post-finasteride syndrome.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

Some dibenzo compounds might help treat cancer with fewer side effects.

Finasteride and dutasteride both increase chromogranin A levels similarly.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Fenugreek extract may help treat benign prostatic hyperplasia.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Suppressing certain hormones might help prevent prostate cancer.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.